Christopher P. Lowe

Director, Hansen Medical.

Companies

Vincerx Pharma, Inc.Board member Dec 28, 2020 to Aug 26, 2022¹
IRulya Therapeutics Inc.Chief executive officer Mar 4, 2022 to Mar 4, 2022²
IRulya Therapeutics Inc.Chief operating officer Feb 11, 2021 to Mar 4, 2022³
IRulya Therapeutics Inc.Chief financial officer May 8, 2019 to Mar 4, 2022⁴
Rebus Holdings, Inc.Board member Aug 18, 2016 to Aug 18, 2016⁵
Rebus Holdings, Inc.Chief executive officer Aug 18, 2016 to Aug 18, 2016⁵
Rebus Holdings, Inc.President Aug 18, 2016 to Aug 18, 2016⁵
Hansen MedicalChief financial officer Jun 12, 2014 to Jul 29, 2016⁶
Hansen MedicalBoard member Nov 15, 2006 to Jul 29, 2016⁷
Hansen MedicalChief executive officer Feb 27, 2014 to May 20, 2014⁸
Anthera PharmaceuticalsChief financial officer Feb 23, 2010 to May 21, 2013⁹
Anthera PharmaceuticalsVP of Administration and CBO Feb 14, 2011 to Jan 7, 2013¹⁰

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Aug 25, 2022Bought 11,600 shares at $1.65 of Vincerx Pharma, Inc.¹²
Aug 24, 2022Bought 18,400 shares at $1.65 of Vincerx Pharma, Inc.¹²
Mar 3, 2022Granted 175,000 shares of IRulya Therapeutics Inc.¹¹
Nov 16, 2021Exercised options 30,000 shares at $2.23 of IRulya Therapeutics Inc.¹³
Oct 5, 2021Sold 4,963 shares at $98.50 of IRulya Therapeutics Inc.¹⁴
Oct 5, 2021Exercised options 4,963 shares at $54.85 of IRulya Therapeutics Inc.¹⁴

The numbers on this page point here. Each one links to the record it came from.